Save Search

1 to 16

Sort By:

Date Target Transaction Type
Value: $mlns
Acquirer Seller
2025-12-15 Generation Bio
Life Science
Cambridge, Massachusetts
www.generationbio.com

Generation Bio is a biotechnology company a new generation of re-dosable, long-lasting gene therapy on a scale to potentially benefit more families living with a broader range of diseases around the world. Generation Bio was founded in 2016 and is based in Cambridge, Massachusetts.

Add-on Acquisition

XOMA Royalty
Company
Life Science
Emeryville, California
www.xoma.com

-
Deal Article Deal Link  
2025-12-15 Tissue Testing Technologies
Life Science
North Charleston, South Carolina
www.tissuetestingtech.com

Tissue Testing Technologies is a biotechnology company specialising in biopreservation .T3's advanced proprietary technologies and services preserve living cells and tissues for clinical and research applications, ensuring the quality and impact of life-saving therapies. Tissue Testing Technologies was founded in 2014 and is based in North Charleston, South Carolina.

Add-on Acquisition

LifeNet Health
Company
Healthcare Services
Virginia Beach, Virginia
www.lifenethealth.org

-
Deal Article Deal Link  
2025-12-15 Piedmont Research Partners
Life Science
Indian Land, South Carolina
www.piedmontresearchpartners.com

Piedmont Research Partners is a clinical research site specializing in Phase II–IV clinical trials across multiple therapeutic areas, including Cardiology, Endocrinology, Rheumatology, GI and Immunology. Piedmont Research Partners is based in Indian Land, South Carolina.

Add-on Acquisition

ObjectiveHealth
Company
Healthcare Services
Franklin, Tennessee
www.objective.health

-
Deal Article Deal Link  
2025-12-15 START Carolinas
Life Science
Myrtle Beach, South Carolina
www.curcmb.com

START Carolinas is a clinical research organisation focused on conducting urologic clinical trials and research studies, particularly in areas such as prostate, bladder, and renal diseases. START Carolinas was founded in 1998 and is based in Myrtle Beach, South Carolina.

Advisor: Bass, Berry & Sims
Add-on Acquisition

START
Company
Life Science
San Antonio, Texas
www.startresearch.com

Advisor: Reed Smith

-
Deal Article Deal Link  
2025-12-13 Arthrosi Therapeutics
Life Science
San Diego, California
www.arthrosi.com

Arthrosi Therapeutics Is focused on developing pozdeutinurad, a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels, flares and tophi in patients with progressive gout. Arthrosi Therapeutics is based in San Diego, California.

Add-on Acquisition
Value

$950

Sobieski & Bradley, Inc.
Company
Insurance
South Jordan, Utah
www.sbins.com

Advisors: McDermott Will & Emery , Barclays Investment Bank

-
Deal Article Deal Link  
2025-12-12 SafePath
Life Science
Carlsbad, California
www.safepath.com

SafePath develops, manufactures, and markets immunoassay diagnostic products and contract manufacturing services for veterinary health and related markets. SafePath was founded in 1995 and is headquartered in Carlsbad, California.

Add-on Acquisition

KVP
Company
Business Services
McKinney, Texas
www.kvpvet.com

-
Deal Article Deal Link  
2025-12-11 Applied Therapeutics
Life Science
New York, New York
www.appliedtherapeutics.com

Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases. Applied Therapeutics is based in New York, New York.

Add-on Acquisition

Cycle Pharmaceuticals
Company
Life Science
Cambridge, United Kingdom
www.cyclepharma.com

-
Deal Article Deal Link  
2025-12-08 Bluejay Therapeutics
Life Science
Redwood City, California
www.bluejaytx.com

Bluejay Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases. The company is currently investigating brelovitug for the treatment of chronic hepatitis delta virus (HDV) and chronic hepatitis B (CHB) viral infections. Additionally, Bluejay is advancing several innovative programs with the goal of developing a combination regimen to achieve a functional cure for chronic hepatitis B, including a proprietary TLR9 agonist (cavrotolimod) and a liver-targeted HBV transcript inhibitor (BJT-628). Bluejay Therapeutics is based in Redwood City, California.

Advisors: Latham & Watkins , J.P. Morgan Securities , Centerview Partners
Add-on Acquisition
Value

$620

Mirum
Company
Life Science
Foster City, California
www.mirumpharma.com

Advisors: Cooley , Morgan Stanley , Cantor Fitzgerald

-
Deal Article Deal Link  
2025-12-08 Total Infusion Care
Life Science
Henderson, Nevada
www.totalinfusioncare.com

Total Infusion Care is a home-infusion speciality pharmacy that provides intravenous therapy and related services for patients transitioning from hospital care to home care. Total Infusion Care was founded in 2012 and is based in Henderson, Nevada.

Advisor: Bailey & Company
Add-on Acquisition

BioMatrix Specialty Pharmacy
Company
Life Science
Plantation, Florida
www.biomatrixsprx.com

-
Deal Article Deal Link  
2025-12-08 Hexas
Life Science
Olympia, Washington
www.hexas.com

Hexas is a biomaterials company that develops regenerative, plant-based raw materials as alternatives to wood, food-crop-derived fuels, and fossil fuel–based feedstocks. The Company grows a proprietary perennial grass (branded XanoGrass) and processes it into a fiber product (XanoFiber) that can be used across industries, including packaging, textiles, composites, energy, and biochemicals, without requiring changes to existing manufacturing systems. Hexas was founded in 2018 and is based in Olympia, Washington.

Add-on Acquisition
Value

$7

Bioleum
Company
Business Services
Oklahoma City, Oklahoma
www.bioleum.com

-
Deal Article Deal Link  
2025-12-05 Foresight Diagnostics
Life Science
Boulder, Colorado
www.foresight-dx.com

Foresight Diagnostics is a precision medicine company developing a novel liquid biopsy test for the measurement of minimal residual disease (MRD) to aid in patient management. Its cell-free DNA testing platform was developed in the labs of two prominent professors at Stanford University and is backed by several major peer-reviewed publications. The company has garnered significant partnering interest from multiple pharmaceutical companies in oncology and is poised for rapid growth. Foresight Diagnostics is headquartered in Boulder, Colorado.

Advisors: Wilson Sonsini Goodrich & Rosati , Centerview Partners
Add-on Acquisition
Value

$450

Natera
Company
Healthcare Services
Austin, Texas
www.natera.com

Advisor: Gibson, Dunn & Crutcher

-
Deal Article Deal Link  
2025-11-27 Orphelia Pharma
Life Science
Paris, France
www.orphelia-pharma.eu

Orphelia Pharma is a French biopharmaceutical company focused on the development and commercialization of medicines for rare pediatric diseases, particularly in neurology and oncology. The Company works on essential medicines with formulations adapted for children, including products with European approvals and others under regulatory review, and conducts research through academic and industrial partnerships. Orphelia Pharma is based in Paris.

Add-on Acquisition

Orphalan
Company
Life Science
Paris, France
www.orphalan.com

-
Deal Article Deal Link  
2025-11-25 Enci Therapeutics
Life Science
South Carolina

Enci Therapeutics is focused on developing therapies for cancer, heart disease, and inflammatory disorders.

Add-on Acquisition

Innova Therapeutics
Company
Life Science
Mt. Pleasant, South Carolina
www.innovatherapeutics.com

-
Deal Article Deal Link  
2025-11-24 Plant Health Care
Life Science
Holly Springs, North Carolina
www.planthealthcare.com

Plant Health Care is a biotechnology company that develops biologically-based crop-health products using patent-protected peptides to boost plant immunity, enhance stress resistance, and improve yields. Plant Health Care is based in Holly Springs, North Carolina.

Add-on Acquisition

PI Industries
Company
Chemicals
Gurgaon, India
www.piindustries.com

-
Deal Article Deal Link  
2025-11-20 Exact Sciences
Life Science
Madison, Wisconsin
www.exactsciences.com

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Exact Sciences was founded in 1995 and is based in Madison, Wisconsin.

Revenue (mlns) 2,759 USD
EBITDA (mlns) 108 USD
Advisors: XMS Capital Partners , Centerview Partners
Add-on Acquisition
Value

$21,000

7.6x Revenue

194.4x EBITDA

Abbott
Company
Medical Products
North Chicago, Illinois
www.abbott.com

Advisors: Wachtell, Lipton, Rosen & Katz , Morgan Stanley

-
Deal Article Deal Link  
2025-11-20 Acera Surgical
Life Science
St. Louis, Missouri
www.acera-surgical.com

Acera Surgical is a bioscience company that develops and commercialises engineered synthetic materials for soft-tissue repair and regenerative wound care. Acera Surgical was founded in 2013 and is based in St. Louis, Missouri.

Advisors: Hogan Lovells , Truist Securities
Add-on Acquisition
Value

$725

Solventum
Company
Diversified
Saint Paul, Minnesota
www.solventum.com

Advisors: McDermott Will & Emery , Morgan Stanley

-
Deal Article Deal Link  
Avg $1,750
71.9x EBITDA
49.4x REVENUE

Try Mergr Free — Access the Full List Today

Stop Manually Tracking Deals.
Get Full Access. Cancel Anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.

Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.

The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.